
|Articles|November 15, 2002
Brimonidine may replace beta-blockers for older patients
Tucson, AZ-Topical beta-blockers have been a mainstay of ongoing treatment for glaucoma for more than 20 years, but a new study adds to the evidence that they may not be the best option for long-term control of IOP for elderly patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
2
Viridian Therapeutics submits Biologics License Application to FDA for veligrotug
3
AAVantgarde Bio closes $141 million Series B financing round
4
 

















































.png)


